政府支持有意义的药物和设备创新：途径与挑战》。

IF 1.6 4区哲学 Q2 ETHICS

Journal of Law Medicine & Ethics Pub Date : 2023-01-01 Epub Date: 2024-03-04 DOI:10.1017/jme.2024.21

Aaron S Kesselheim

引用次数: 0

摘要

美国政府支持药物创新。因此，政府在购买昂贵的处方药和医疗器械时，必须区分高价值和低价值创新，确保不断发现变革性药物，避免浪费患者和纳税人的资金。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Government Support of Meaningful Drug and Device Innovation: Pathways and Challenges.

The US government supports drug innovation. It is therefore crucial that it distinguish between high-value and low-value innovation in purchasing expensive prescription drugs and medical devices and ensure the continued discovery of transformative drugs and that patient and taxpayer funds are not wasted.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Law Medicine & Ethics 医学-医学：法

CiteScore

2.90

自引率

4.80%

发文量

审稿时长

6-12 weeks

期刊介绍： Material published in The Journal of Law, Medicine & Ethics (JLME) contributes to the educational mission of The American Society of Law, Medicine & Ethics, covering public health, health disparities, patient safety and quality of care, and biomedical science and research. It provides articles on such timely topics as health care quality and access, managed care, pain relief, genetics, child/maternal health, reproductive health, informed consent, assisted dying, ethics committees, HIV/AIDS, and public health. Symposium issues review significant policy developments, health law court decisions, and books.